EcoDrugPlus

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSOMYG00000015253
Gene Symbol: ESRRGA
1 Cross references
197 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOMYG00000035963
Gene Symbol: XPO1
1 Cross references
218 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOMYG00000062205
Gene Symbol: XPO1
1 Cross references
208 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOMYG00000018989
Gene Symbol: XPO1
1 Cross references
218 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSOMYG00000048301
Gene Symbol: FDPS
1 Cross references
263 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSOMYG00000065726
Gene Symbol: FDPS
1 Cross references
263 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSOMYG00000018653
Gene Symbol: FDFT1
1 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSOMYG00000035581
Gene Symbol: FNTA
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSOMYG00000045716
Gene Symbol: FNTA
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSOMYG00000054068
Gene Symbol: FNTB
1 Cross references
201 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSOMYG00000040651
Gene Symbol: FGFR1A
1 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSOMYG00000031327
Gene Symbol: FGFR1A
1 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).